Journey Martinez

Featured in: Favicon

jamanetwork.com Favicon

Articles

Mortality and Morbidity Among Individuals With Hypertension Receiving a Diuretic, ACE Inhibitor, or Calcium Channel Blocker: A Secondary Analysis of a Randomized Clinical Trial | Cardiology | JAMA Network Open | JAMA Network

Dec 4, 2023 | jamanetwork.com | Jose-Miguel Yamal |Mikala C. Osani |Zimmer Biomet |Journey Martinez

Key PointsQuestion Is there a difference in the long-term risk of mortality and morbidity outcomes for adults with hypertension starting 1 of 3 antihypertensive treatments: thiazide-type diuretic, calcium channel blocker, or angiotensin-converting enzyme (ACE) inhibitor?

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →